Evidence map›Paper›PMID 39340754›Full record

ReviewBiotechnology letters2024

Research progress in the biosynthesis of xylitol: feedstock evolution from xylose to glucose.

Xin-Yu Zhang, Xi-Min Zhao, Xin-Yu Shi, Ying-Jie Mei, Xiao-Jie Ren, Xin-He Zhao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Biotechnology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xin-Yu ZhangFood & Medicine Homology and Chinese Medicine Health Science Institute, Shandong University of Technology, Shandong, China.ORCID http://orcid.org/0009-0003-9783-5011
Xi-Min ZhaoZibo Occupational Disease Prevention and Control Hospital/Zibo Sixth People's Hospital, Shandong, China.
Xin-Yu ShiZibo Product Quality Testing Research Institute, Shandong, China.
Ying-Jie MeiZibo Institute for Food and Drug Control, Shandong, China.
Xiao-Jie RenFood & Medicine Homology and Chinese Medicine Health Science Institute, Shandong University of Technology, Shandong, China. renxiaojie2020@163.com.
Xin-He ZhaoFood & Medicine Homology and Chinese Medicine Health Science Institute, Shandong University of Technology, Shandong, China. zhaoxinhe@sdut.edu.cn.

Funding

Natural Science Foundation of Shandong Province ZR2020MC201Natural Science Foundation of Shandong Province ZR2023MC194Promoting scientiffc research cooperation and highlevel talent cultivation projects with Canada, Australia, New Zealand, and Latin America 2022-1007
6 · The paper itself

Abstract

Xylitol, as an important food additive and fine chemical, has a wide range of applications, including food, medicine, chemical, and feed. This review paper focuses on the research progress of xylitol biosynthesis, from overcoming the limitations of traditional chemical hydrogenation and xylose bioconversion, to the full biosynthesis of xylitol production using green and non-polluting glucose as substrate. In the review, the molecular strategies of wild strains to increase xylitol yield, as well as the optimization strategies and metabolic reconfiguration during xylitol biosynthesis are discussed. Subsequently, on the basis of existing studies, the paper further discusses the current status of research and future perspectives of xylitol production using glucose as a single substrate. The evolution of raw materials from xylose-based five-carbon sugars to glucose is not only cost-saving, but also safe and environmentally friendly, which brings new opportunities for the green industrial chain of xylitol.

Indexed as

GlucoseXylitolXyloseMetabolic EngineeringGlucoseXylitolXyloseFully biological approachGlucose fermentationOptimization strategyStrain breedingXylitol biosynthesisXylose fermentation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.